Main > ENDOCRINOLOGY > Diabetes. Treatment > VildaGliptin (DPP-IV Inhibitor) > Co.: CH. N. (EU Approved/Patents) > Patent>DisClosure



Patent>DisClosure's subsections
Assignee, Claims, No., Etc.

Patent>DisClosure's products
This section has no products